Member Info for Toukankahmoon

Strangely I find this explanation of why SP is what it is, all rather comforting.

I’m not buying more at the moment and certainly not selling.

It has been a tortuous rollercoaster for the four years I’ve been invested but if arm 2 delivers I won’t be bailing out at 1.88 that would be mad.

No

Not until 2H24 when arm 2 results released. But remember it is only a safety trial.

Bein

Because true seasoned investors show no compassion, laugh in the face of high risk, put all their money into one share and blow the holiday fund to boot.

You really crack me up. I hope for your sake this comes good in a big way in a really short timescale.

Wyndrum

Has said that he’s a shareholder because he believes his will come good but not that it is inevitable.

I totally agree and that is why to make Avacta a large percentage of one’s investment portfolio is foolhardy.

On the other point, given then the stock market and the government are all so untrustworthy, it’s lucky that the pharmaceutical industry is pure as the driven snow

CTSFO

Thanks

Strangy

Nothing you posted contradicts what I posted.

But the enemy of a gambler is greed whether in chasing the dead cert or trying to regain losses.

I’m not saying you are that sort of investor.

But I certainly wouldn’t invest more than 20% of my investment capital in any one share regardless

Knew I could rely on the Pom Pom girls to misconstrue my post so they could have sh*t throwing contest.

My point was that I am happy to risk what I can afford to lose in the hope that I will make a decent amount of money than double down and risk losing an amount I cannot afford to lose in the greedy hope that I’ll make a much larger amount. What do you find so hard to understand in that even though you might not agree presumably because you’re greedy.

Sometimes leads to investing more than you can afford to lose!

If Avacta went to £10 ( unlikely) I’d have £500k and be happy with it. Say doubling my investment and therefore risk gets me £1M but what’s the point if I’m happy with £500k. On the other hand if it all goes wrong then losing £50k isn’t going to bother me but losing £100k certainly is.

In layman’s terms what exactly does “widening the therapeutic index” mean?

BV is correct

The last time I was involved in an important vote I was contacted by HL who then voted according to the majority of their customers wishes. However I doubt the AGM re elections are important enough for this to happen. But no harm in asking

Herekitty

Greed is not a great attribute when investing

As I posted last week:

The customised vaccine approach is where the investment is going:

1. It doesn’t have to be targeted to the tumour area

2. It promises a total cure with no chance of recurrence

3. Treatment is shorter and less invasive

4. It doesn’t have the ‘fear’ factor of chemo

5. It’s sexy

Latin would stop any ambiguity and appeal to the legals.

Let’s face it we are all in the dark until arm 2 results are published. And fudsters and Pom Pom girls all want those results to be unequivocal. That still doesn’t guarantee riches beyond belief but at least it’s a major step in the right direction.

There is little difference between the two main tribes on here other than a lot of the Pom Pom girls just cannot control their emotions and abusive language.

Chief

ditto, makes me despair of the vitriol from some posters

Energy

Going for argumentative sad of the year. Picks throwaway comment at the end of my post to have a go at me. Is that because you couldn’t argue with the main thrust. You must be a very angry person.

Cost of developing a personalised treatment has been cited as a barrier to vaccines but these costs will fall and I would think that cost of administering the vaccine would be far less than 6 months of chemotherapy. With the added bonus of less chance of the cancer recurring, then this has got to be a treatment method worth pursuing.

Absolutely excellent. The clearest statement of where we are and where we are going. Also a strong hint as to why the fund raise had to be done right then - in order to state going concern for next 12 months.

In terms of having funds for completion of P2 and beyond: the “everything is on the table” remark seems to covering other fund raises rather than a TO. I know that I changed my view after Al went, but I’m now going back to putting more weight on CC’s statement that the favoured way forward is licensing say 3996. Although I still like Novartis as a partner.

But as I say, the least ambiguous communication yet.

AgentB

Just one example of competing treatments and one that promises long term efficacy and protection against returning cancer. This sort of development is getting all the interest and resources because chemotherapy has a bad press and there is always the possibility for the cancer to return. Whereas this type of vaccine promises a permanent cure.

Those folk who say Avacta can take as long as it takes are wrong. The competition will “eat our lunch” if we can’t get on with it.

Ice

Aaah so if each RNS pushes a target further away then that isn’t missing the target. No wonder projects in the UK are often woefully late.